BANK VONTOBEL/CALL/SANOFI/94/0.1/21.03.25 Share Price

Warrant

DE000VD3HX71

Market Closed - Boerse Frankfurt Warrants 19:04:09 16/07/2024 BST
0.7 EUR -6.67% Intraday chart for BANK VONTOBEL/CALL/SANOFI/94/0.1/21.03.25
Current month+7.69%
1 month+45.83%
Date Price Change
16/07/24 0.7 -6.67%
15/07/24 0.75 -10.71%
12/07/24 0.84 +1.20%
11/07/24 0.83 -1.19%
10/07/24 0.84 +12.00%

Real-time Boerse Frankfurt Warrants

Last update July 16, 2024 at 07:04 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VD3HX7
ISINDE000VD3HX71
Date issued 05/04/2024
Strike 94
Maturity 21/03/2025 (248 Days)
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.89
Lowest since issue 0.36
Spread 0.06
Spread %7.89%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
91.92 EUR
Average target price
108.6 EUR
Spread / Average Target
+18.10%
Consensus